Toward high-resolution modeling of small molecule-ion channel interactions

Area of Science:

• Computational chemistry
• Structural biology
• Pharmacology

Background:

• Ion channels are crucial drug targets for neurological, autoimmune, and cardiovascular diseases.
• Structure-guided drug design is increasingly used to develop potent and selective ion channel modulators.
• Accurate prediction of ligand binding poses is vital for successful drug discovery.

Purpose of the Study:

• To evaluate the performance of RosettaLigand and GALigandDock in modeling ligand-ion channel complexes.
• To assess the accuracy of sampling and scoring for known ligand-channel interactions.
• To provide insights into optimizing computational approaches for ion channel drug design.

Main Methods:

• Docking of known ligands to voltage-gated sodium (Na_V), calcium (Ca_V), and TRPV channel structures using RosettaLigand and GALigandDock.
• Analysis of ligand-binding pose accuracy using root mean square deviation (RMSD) against experimental data.
• Evaluation of scoring function performance in identifying native ligand poses.

Main Results:

• Both RosettaLigand and GALigandDock successfully sampled ligand-binding poses within 1-2 Å RMSD of experimental coordinates.
• Scoring functions of both methods did not consistently rank the experimental ligand poses as the top models.
• Performance varied, indicating limitations in current scoring for these systems.

Conclusions:

• RosettaLigand and GALigandDock show potential for sampling correct ligand poses for ion channels.
• Current scoring functions require careful assessment and may not reliably identify the best poses.
• Optimized scoring criteria, considering receptor flexibility and specific interactions, are needed for reliable structure-guided ion channel drug design.